Biological characterization of two xenografts derived from human CUPs (carcinomas of unknown primary)
2007

Biological characterization of two xenografts derived from human CUPs

Sample size: 4 publication Evidence: moderate

Author Information

Author(s): Lequin Delphine, Fizazi Karim, Toujani Saloua, Souquère Sylvie, Mathieu Marie-Christine, Hainaut Pierre, Bernheim Alain, Praz Françoise, Busson Pierre

Primary Institution: Université Paris-Sud, CNRS-UMR 8126 and Institut Gustave Roussy

Hypothesis

Can xenografts be successfully established from clinical specimens of carcinomas of unknown primary (CUP)?

Conclusion

Xenografted tumors can be obtained from a substantial fraction of CUP clinical specimens, and the Capi3 cell line will be a useful tool for assessing novel c-kit inhibitors.

Supporting Evidence

  • Successful xenografts were achieved in 2 cases out of 4.
  • One xenograft (Capi3) has been adapted to in vitro culture and is available for research.
  • Both xenografts displayed histological characteristics of adenocarcinomas.
  • Distinct TP53 gene mutations were detected in both xenografts.
  • Intense membrane expression of c-kit was recorded in Capi3.

Takeaway

The researchers tried to grow tumors from patients with unknown primary cancers in mice, and they succeeded with two out of four attempts. One of these tumors can now be studied in the lab.

Methodology

Xenografts were attempted using tumor fragments from patients implanted in immunodeficient mice, followed by in vitro culture of the resulting malignant cells.

Limitations

Only two successful xenografts were achieved out of four attempts, limiting the generalizability of the findings.

Participant Demographics

4 patients with carcinomas of unknown primary, including 3 females and 1 male, aged 34 to 66.

Digital Object Identifier (DOI)

10.1186/1471-2407-7-225

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication